Incyte Corporation
Stock Details
Is it expensive?
Trailing P/E Ratio
14.30
Forward P/E Ratio
11.17
PEG Ratio
0.17
10.49
Price-to-Sales (TTM)
3.77
3.60
28.12
Market Cap
20.45B
16.25B
Is it profitable?
Net Profit Margin (TTM)
26.71%
Gross Profit Margin
91.79%
Diluted EPS (TTM)
7.08
30.82%
5.36B
Is it growing?
20.90%
91.70%
Is it risky?
0.80
0.70
3.68
39.43M
Who owns it?
106.51%
1.89%
9.52%
199.95M
167.82M
Does it pay?
0.00%
0.00%
--
--
How much cash?
4.02B
1.52B
558.87M
20.10
- Price
- 102.38
- Percent Change
- +1.14 (1.13%)
- Previous Close
- 101.24
- Open
- 100.81
- Low
- 100.74
- High
- 106.37
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$102.38
From 52W Low
+53.40%
From 52W High
-8.83%
Today
+1.13%
1Y Change
+48.87%
6M
$96.70
3M
$95.94
1M
$99.85
Today
$102.38
From 52W Low
+53.40%
From 52W High
-8.83%
Today
+1.13%
1Y Change
+48.87%
6M
$96.70
3M
$95.94
1M
$99.85
Today
$102.38
Above Average
within its 1-year price range
$102.38
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+2.5%
3M
+6.7%
6M
+5.9%
1Y
+48.9%
Rate of Change (ROC)
Neutral
Price is rising 1.1x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Incyte Corporation
- Founded
- 1991
- CEO
- William J. Meury
- Employees
- 2,844
- Fiscal Year End
- Dec 31, 2024
- Address
1801 Augustine Cut-off
Wilmington
Delaware
19803
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.incyte.com
Indicators
Operating Cash Flow
1.52B
Net Income
1.43B
Backed by Cash
1.06
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
S&P 500Index S&P 500 - SPX |
Indicators
Operating Cash Flow
1.52B
Net Income
1.43B
Backed by Cash
1.06
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
14.30
Forward P/E Ratio
11.17
PEG Ratio
0.17
10.49
Price-to-Sales (TTM)
3.77
3.60
28.12
Market Cap
20.45B
16.25B
Is it profitable?
Net Profit Margin (TTM)
26.71%
Gross Profit Margin
91.79%
Diluted EPS (TTM)
7.08
30.82%
5.36B
Is it growing?
20.90%
91.70%
Is it risky?
0.80
0.70
3.68
39.43M
Who owns it?
106.51%
1.89%
9.52%
199.95M
167.82M
Does it pay?
0.00%
0.00%
--
--
How much cash?
4.02B
1.52B
558.87M
20.10
- Price
- 102.38
- Percent Change
- +1.14 (1.13%)
- Previous Close
- 101.24
- Open
- 100.81
- Low
- 100.74
- High
- 106.37
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$102.38
From 52W Low
+53.40%
From 52W High
-8.83%
Today
+1.13%
1Y Change
+48.87%
6M
$96.70
3M
$95.94
1M
$99.85
Today
$102.38
From 52W Low
+53.40%
From 52W High
-8.83%
Today
+1.13%
1Y Change
+48.87%
6M
$96.70
3M
$95.94
1M
$99.85
Today
$102.38
Above Average
within its 1-year price range
$102.38
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+2.5%
3M
+6.7%
6M
+5.9%
1Y
+48.9%
Rate of Change (ROC)
Neutral
Price is rising 1.1x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Incyte Corporation
- Founded
- 1991
- CEO
- William J. Meury
- Employees
- 2,844
- Fiscal Year End
- Dec 31, 2024
- Address
1801 Augustine Cut-off
Wilmington
Delaware
19803
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.incyte.com
Related Heatmaps
S&P 500Index S&P 500 - SPX |